ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.

Martin Schuler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.